These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10521308)

  • 1. Pseudoautosomal linkage of Hodgkin disease.
    Horwitz M; Wiernik PH
    Am J Hum Genet; 1999 Nov; 65(5):1413-22. PubMed ID: 10521308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudoautosomal linkage of Hodgkin disease.
    Whittemore AS; Shih MC
    Am J Hum Genet; 2000 Aug; 67(2):535-7. PubMed ID: 10889053
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis.
    Shears DJ; Vassal HJ; Goodman FR; Palmer RW; Reardon W; Superti-Furga A; Scambler PJ; Winter RM
    Nat Genet; 1998 May; 19(1):70-3. PubMed ID: 9590293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel class of Pseudoautosomal region 1 deletions downstream of SHOX is associated with Leri-Weill dyschondrosteosis.
    Benito-Sanz S; Thomas NS; Huber C; Gorbenko del Blanco D; Aza-Carmona M; Crolla JA; Maloney V; Rappold G; Argente J; Campos-Barros A; Cormier-Daire V; Heath KE
    Am J Hum Genet; 2005 Oct; 77(4):533-44. PubMed ID: 16175500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the first recurrent PAR1 deletion in Léri-Weill dyschondrosteosis and idiopathic short stature reveals the presence of a novel SHOX enhancer.
    Benito-Sanz S; Royo JL; Barroso E; Paumard-Hernández B; Barreda-Bonis AC; Liu P; Gracía R; Lupski JR; Campos-Barros Á; Gómez-Skarmeta JL; Heath KE
    J Med Genet; 2012 Jul; 49(7):442-50. PubMed ID: 22791839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined segregation and linkage analysis of 59 Hodgkin's disease families indicates the role of HLA determinants.
    Shugart YY; Collins A
    Eur J Hum Genet; 2000 Jun; 8(6):460-3. PubMed ID: 10878668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mosaic compound heterozygosity of SHOX resulting in Leri-Weill dyschondrosteosis with marked short stature: implications for disease mechanisms and recurrence risks.
    Reish O; Huber C; Altarescu G; Chapman-Shimshoni D; Levy-Lahad E; Renbaum P; Mashevich M; Munnich A; Cormier-Daire V
    Am J Med Genet A; 2010 Sep; 152A(9):2230-5. PubMed ID: 20683993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic analysis of a family with a history of Hodgkin's disease and dyschondrosteosis.
    Gokhale DA; Evans DG; Crowther D; Woll P; Watson CJ; Dearden SP; Fergusson WD; Stevens RF; Taylor GM
    Leukemia; 1995 May; 9(5):826-33. PubMed ID: 7769845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudoautosomal locus for schizophrenia excluded in 12 pedigrees.
    Wang ZW; Black D; Andreasen N; Crowe RR
    Arch Gen Psychiatry; 1993 Mar; 50(3):199-204. PubMed ID: 8439240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHOX gene mutations and deletions in dyschondrosteosis or Leri-Weill syndrome.
    Cormier-Daire V; Belin V; Cusin V; Viot G; Girlich D; Toutain A; Moncla A; Vekemans M; Le Merrer M; Munnich A
    Acta Paediatr Suppl; 1999 Dec; 88(433):55-9. PubMed ID: 10626546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA Methylation Status of SHOX-Flanking CpG Islands in Healthy Individuals and Short Stature Patients with Pseudoautosomal Copy Number Variations.
    Ogushi K; Hattori A; Suzuki E; Shima H; Izawa M; Yagasaki H; Horikawa R; Uetake K; Umezawa A; Ishii T; Muroya K; Namba N; Tanaka T; Hirano Y; Yamamoto H; Soneda S; Matsubara K; Kagami M; Miyado M; Fukami M
    Cytogenet Genome Res; 2019; 158(2):56-62. PubMed ID: 31158835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular evaluation of SHOX/PAR1 duplications in Leri-Weill dyschondrosteosis (LWD) and idiopathic short stature (ISS).
    Benito-Sanz S; Barroso E; Heine-Suñer D; Hisado-Oliva A; Romanelli V; Rosell J; Aragones A; Caimari M; Argente J; Ross JL; Zinn AR; Gracia R; Lapunzina P; Campos-Barros A; Heath KE
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E404-12. PubMed ID: 21147883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the first PAR1 deletion encompassing upstream SHOX enhancers in a family with idiopathic short stature.
    Benito-Sanz S; Aza-Carmona M; Rodríguez-Estevez A; Rica-Etxebarria I; Gracia R; Campos-Barros A; Heath KE
    Eur J Hum Genet; 2012 Jan; 20(1):125-7. PubMed ID: 22071895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dental and Maxillofacial Signs in Leri-Weill Dyschondrosteosis.
    Depeyre A; Schlund M; Nicot R; Ferri J
    J Oral Maxillofac Surg; 2019 Apr; 77(4):762-768. PubMed ID: 30529377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of Xpter encompassing the SHOX gene and PAR1 region in familial patients with Leri-Weill Dyschondrosteosis syndrome.
    Mutesa L; Vanbellinghen JF; Hellin AC; Segers K; Jamar M; Pierquin G; Bours V
    Genet Couns; 2009; 20(1):9-17. PubMed ID: 19400538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic and nonallelic heterogeneity in dyschondrosteosis (Leri-Weill syndrome).
    Cormier-Daire V; Huber C; Munnich A
    Am J Med Genet; 2001; 106(4):272-4. PubMed ID: 11891678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the first de novo PAR1 deletion downstream of SHOX in an individual diagnosed with Léri-Weill dyschondrosteosis (LWD).
    Barroso E; Benito-Sanz S; Belinchón A; Yuste-Checa P; Gracia R; Aragones A; Campos-Barros A; Heath KE
    Eur J Med Genet; 2010; 53(4):204-7. PubMed ID: 20412871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SHOX region and its mutations.
    Capone L; Iughetti L; Sabatini S; Bacciaglia A; Forabosco A
    J Endocrinol Invest; 2010 Jun; 33(6 Suppl):11-4. PubMed ID: 21057179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's disease susceptibility: linkage to the HLA locus demonstrated by a new concordance method.
    Berberich FR; Berberich MS; King MC; Engleman EG; Grumet FC
    Hum Immunol; 1983 Apr; 6(4):207-17. PubMed ID: 6221004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound heterozygosity of SHOX-encompassing and downstream PAR1 deletions results in Langer mesomelic dysplasia (LMD).
    Campos-Barros A; Benito-Sanz S; Ross JL; Zinn AR; Heath KE
    Am J Med Genet A; 2007 May; 143A(9):933-8. PubMed ID: 17394206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.